Brief: Elicera Therapeutics Q3 Adjusted EPS SEK -0.16
14/11/2023 07:12
Nov 14 (Reuters) - Elicera Therapeutics Q3 adjusted EPS SEK -0.16
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application